Highlights of G-BA’s annual report 2020
The G-BA has recently published its annual report from last year, 2020. Key statistics on the early benefit assessments The number of
Tag: G-BA
8 NUB assessments of high-risk medical devices (§ 137h)
Hospitals can treat patients with novel methods as soon as they become available. The treatment is reimbursed by SHI funds within the
Joint HTAs are finally coming to Germany
It’s been a long time in the making, but now the G-BA finally accepted a compromise on joint HTAs conducted at the
G-BA meetings
Ever wondered if patients influence the G-BA decision-making?
Orphan drug re-assessments
What happens when the sales for an orphan drug exceed €50 mn in a 12 months period?